Urology Devices Market by Product (Dialysis, Laser, Lithotripsy, Robotic, Insufflators, Guidewires, Catheters, Stents, Implants), Application (Kidney Diseases, Cancer, Pelvic Organ Prolapse, BPH, Stones), End User, and Region - Global Forecast to 2028
상품코드:1390418
리서치사:MarketsandMarkets
발행일:2023년 11월
페이지 정보:영문 268 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
보고서 개요
조사 범위
조사 대상년도
2021-2028년
기준년도
2022년
예측 기간
2023-2028년
단위
금액(USD)
부문
제품, 용도, 최종사용자, 지역
대상 지역
북미, 유럽, 아시아태평양, 중남미, 중동 & 아프리카
비뇨기과 기기 시장 규모는 2023년 341억 달러로 추정되며, 예측 기간 동안 7.3의 CAGR을 기록하며 2028년에는 486억 달러 규모로 성장할 것으로 예상됩니다.
당뇨병이나 혈압과 같은 만성 질환의 발생률이 증가함에 따라 치료나 외과적 개입이 필요한 비뇨기 및 신장 질환의 유병률이 증가하고 있습니다. 이러한 환자들을 관리하기 위해서는 긴급하고 시기적절한 치료가 필요합니다. 저침습적 시술의 전반적인 증가는 시술의 안전과 성공을 보장하기 위해 비뇨기과 장치의 채택 증가로 이어졌습니다. 이는 전체 시장의 성장을 주도하고 있습니다.
제품별로는 소모품 및 액세서리 부문이 예측 기간 동안 가장 큰 성장을 보일 것으로 예상됩니다. 신장 질환 및 암과 같은 질병의 발생률 증가가 이 부문의 성장을 주도하고 있습니다. 또한, 만성 질환 치료에 대한 R&D에 대한 관심이 높아짐에 따라 이 시장의 성장을 가속하고 있습니다.
용도별로는 신장 질환 부문이 가장 높은 성장률을 보이고 있습니다. 노령 인구 증가와 신장에 영향을 미치는 만성 질환의 발생률 증가가 이 부문의 성장을 가속하는 주요 요인입니다.
세계의 비뇨기과 기기 시장을 조사했으며, 시장 개요, 시장 성장에 미치는 각종 영향요인 및 시장 기회 분석, 기술 및 특허 동향, 사례 조사, 규제 환경, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 프리미엄 인사이트
제5장 시장 개요
시장 역학
성장 촉진요인
성장 억제요인
기회
과제
가격 분석
밸류체인 분석
공급망 분석
특허 분석
무역 분석
에코시스템 및 시장 맵
Porter의 Five Forces 분석
PESTLE 분석
규제 분석
주요 컨퍼런스 및 이벤트
기술 분석
고객 사업에 영향을 미치는 동향/파괴적 변화
주요 이해관계자와 구입 기준
사례 연구
제6장 비뇨기 디바이스 시장 : 제품별
기기
투석 디바이스
내시경
레이저 및 쇄석술 디바이스
내시경 및 영상 시스템
로봇 시스템
흡인기
내시경 유체 관리 시스템
요역동학 시스템
기타
소모품 및 부속품
투석 소모품
카테터
가이드와이어
회수 디바이스 및 추출 디바이스
외과용 해부기/겸자/바늘 홀더
확장기 세트 및 요도 액세스 시스
스텐트 및 임플란트
생검 장치
튜브 및 원위 부착물
배수 백
기타
제7장 비뇨기 디바이스 시장 : 용도별
신장병
비뇨기암
골반 장기 탈출증
전립선 비대증
요실금
발기부전
요로 결석
기타
제8장 비뇨기 디바이스 시장 : 최종사용자별
병원/ASC/클리닉
투석센터
홈케어
제9장 비뇨기과디바이스 시장 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
제10장 경쟁 구도
개요
주요 전략/유력 기업
매출 점유율 분석
시장 점유율 분석
기업 평가 매트릭스
중소기업/신규 기업 평가 매트릭스
경쟁 시나리오와 동향
제11장 기업 개요
주요 기업
FRESENIUS MEDICAL CARE AG & CO. KGAA
BAXTER INTERNATIONAL, INC.
BOSTON SCIENTIFIC CORPORATION
BECTON, DICKINSON AND COMPANY
B. BRAUN MELSUNGEN AG
CARDINAL HEALTH
OLYMPUS CORPORATION
INTUITIVE SURGICAL
COLOPLAST A/S
STRYKER CORPORATION
TELEFLEX INCORPORATED
CONVATEC GROUP PLC
MEDTRONIC PLC
기타 기업
KARL STORZ
COOK MEDICAL
RICHARD WOLF GMBH
COMPACTCATH
DORNIER MEDTECH
NIKKISO CO., LTD.
DIALIFE SA
ERBE VISION
WELL LEAD MEDICAL CO., LTD.
ROCAMED
ENDOMED SYSTEMS GMBH
AMSINO INTERNATIONAL, INC.
MEDISPEC
MEDICAL TECHNOLOGIES OF GEORGIA
VIMEX SP. Z O. O.
BALTON SP. Z O.O.
HUNTER UROLOGY(PART OF OPTIMUM MEDICAL GROUP)
RIBBEL INTERNATIONAL LIMITED
제12장 부록
LSH
영문 목차
영문목차
Report Description
Scope of the Report
Years Considered for the Study
2021-2028
Base Year
2022
Forecast Period
2023-2028
Units Considered
Value (USD) Billion
Segments
Product, application, end user, and region
Regions covered
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
The urology devices market is valued at an estimated USD 34.1 billion in 2023 and is projected to reach USD 48.6 billion by 2028, at a CAGR of 7.3% during the forecast period. Increase in the incidence of chronic diseases like diabetes and blood pressure has led to the increase in prevalence of the urological and kidney conditions which require care and surgical interventions. Urgent and timely treatment is required to manage these patients. The overall increase in the number of minimally invasive procedures is leading to the increased adoption of urology devices in order to ensure the safe and success of the procedures. This is driving the overall growth of the market.
"Consumables & accessories segment accounted for the highest growth rate in the urology devices market, by product, during the forecast period."
The urology devices market is bifurcated into instruments and consumables & accessories on the basis of product. The instrument segment in the urology devices market is experiencing substantial growth, largely driven by the increasing incidence of diseases such as kidney diseases and cancers. Consumables & accessories segment is also growing due to the rising focus on R&D for the treatment of increasing incidence of chronic diseases.
"kidney diseases segment accounted for the highest growth rate in the urology devices market, by applications, during the forecast period."
The global urology devices market is bifurcated into kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications. The kidney diseases segment is currently witnessing the highest growth rate within the urology devices market. The rising geriatric population and rising incidence of chronic diseases affecting kidneys are the major factors driving this segment's growth.
"Dialysis centers segment accounted for the highest CAGR."
Based on end users, the urology devices market is segmented into hospitals, ASCs, and clinics, dialysis centers and home care settings. In 2020, the dialysis centers segment accounted for the highest growth rate. This can be attributed to the increased demand for advanced dialysis products and facilities for ESRD treatment.
"Asia Pacific: The fastest-growing region urology devices market."
The global urology devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the rising geriatric population, increasing prevalence of diabetes, high burden of kidney diseases such as CKD, increasing healthcare spending, growing per capita income, rising demand for cutting-edge technologies, expansion of private-sector hospitals to rural areas in various APAC countries, and the presence of high-growth markets are driving the growth of the urology devices market in this region.
The break-up of the profile of primary participants in the urology devices market:
By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
By Designation: C-level - 27%, D-level - 18%, and Others - 55%
By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%
The key players in urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cardinal Health (US), Olympus Corporation (Japan), Intuitive Surgical (US), Coloplast A/S (Denmark), Stryker Corporation (US), Teleflex Incorporated (US), Convatec Group PLC (UK), Medtronic PLC (Ireland), Karl Storz (Germany), Cook Medical (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Dialife SA (Switzerland), Erbe Vision (Germany), Well Lead Medical Co., Ltd. (China), ROCAMED (Germany), EndoMed Systems GmbH (Germany), Amniso International, Inc. (US), Medispec (US), Medical Technologies of Georgia (US), Vimex Sp. z o.o. (Poland), Balton Sp. z o.o. (Poland), Hunter Urology (UK), Ribbel International Ltd. (India).
Research Coverage:
This research report categorizes the urology devices market by product (instruments and consumables & accessories), application (kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications), end user (hospitals, ASCS & clinics, dialysis centers and home care settings), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities and challenges, influencing the growth of the urology devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions and services, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the urology devices market. Competitive analysis of upcoming startups in the urology devices market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urology devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities and challenges.
The report provides insights on the following pointers:
Analysis of key drivers (Rising incidence of urological diseases, growing preference for minimally invasive procedures, rising focus on R&D and product launches, growing number of hospitals and surgical centers), restraints (high degree of consolidation among key players), opportunities (potential growth opportunities in emerging economies, technological advancements) and challenges (increasing number of product recalls by key players, shortage of skilled urologists) influencing the growth of the urology devices market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urology devices market.
Market Development: Comprehensive information about lucrative markets - the report analyses the urology devices market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urology devices market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), among others in the urology devices market strategies.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKETS COVERED
1.4.2 REGIONS COVERED
1.4.3 YEARS CONSIDERED
1.4.4 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT: UROLOGY DEVICES MARKET
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 4 COMPANY REVENUE ESTIMATION IN UROLOGY DEVICES MARKET
2.2.1.1 Presentations of companies and primary interviews
2.2.1.2 Growth forecast
2.2.1.3 CAGR projections
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.2 TOP-DOWN APPROACH
FIGURE 6 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 GROWTH RATE ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: UROLOGY DEVICES MARKET
2.8 IMPACT OF ECONOMIC RECESSION ON UROLOGY DEVICES MARKET
3 EXECUTIVE SUMMARY
FIGURE 8 UROLOGY DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 9 UROLOGY DEVICES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 10 UROLOGY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 11 UROLOGY DEVICES MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 UROLOGY DEVICES MARKET OVERVIEW
FIGURE 12 RISING PREVALENCE OF UROLOGICAL DISEASES TO DRIVE MARKET
4.2 UROLOGY DEVICES MARKET, BY PRODUCT, 2023 VS. 2028
FIGURE 13 INSTRUMENTS TO DOMINATE UROLOGY DEVICES MARKET DURING FORECAST PERIOD
4.3 UROLOGY DEVICES MARKET, BY APPLICATION, 2023 VS. 2028
FIGURE 14 KIDNEY DISEASES TO COMMAND LARGEST MARKET SHARE IN 2028
4.4 UROLOGY DEVICES MARKET, BY END USER, 2023 VS. 2028
FIGURE 15 HOSPITALS, ASCS, AND CLINICS SEGMENT TO DOMINATE MARKET DURING STUDY PERIOD
TABLE 125 INDIA: UROLOGY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 126 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 127 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 128 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 129 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RISING PREVALENCE OF CHRONIC DISEASES AND GROWING PATIENT POOL TO DRIVE MARKET
TABLE 130 LATIN AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 131 LATIN AMERICA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 132 LATIN AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 133 LATIN AMERICA: UROLOGY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
9.5.2 LATIN AMERICA: RECESSION IMPACT
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASING HEALTHCARE EXPENDITURE AND IMPROVING HEALTHCARE SYSTEM TO DRIVE MARKET
TABLE 134 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 135 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY STRATEGIES/RIGHT TO WIN
TABLE 138 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN UROLOGY DEVICES MARKET
10.3 REVENUE SHARE ANALYSIS
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS
10.4 MARKET SHARE ANALYSIS
FIGURE 28 UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 139 DEGREE OF COMPETITION: UROLOGY DEVICES MARKET
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 29 COMPANY EVALUATION MATRIX, 2022
10.5.5 COMPANY FOOTPRINT
FIGURE 30 PRODUCT AND REGIONAL FOOTPRINT
TABLE 140 PRODUCT FOOTPRINT
TABLE 141 REGIONAL FOOTPRINT
10.6 SME/START-UP EVALUATION MATRIX
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
FIGURE 31 START-UP/SME EVALUATION MATRIX, 2022
10.6.5 COMPETITIVE BENCHMARKING
TABLE 142 COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 143 DETAILED LIST OF KEY START-UPS/SMES
10.7 COMPETITIVE SCENARIOS AND TRENDS
10.7.1 KEY PRODUCT LAUNCHES & APPROVALS
TABLE 144 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2020-OCTOBER 2023
10.7.2 KEY DEALS
TABLE 145 KEY DEALS, JANUARY 2020-OCTOBER 2023
10.7.3 OTHER KEY DEVELOPMENTS
TABLE 146 OTHER KEY DEVELOPMENTS, JANUARY 2020-OCTOBER 2023
11 COMPANY PROFILES
(Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
11.1 KEY PLAYERS
11.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA
TABLE 147 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY OVERVIEW
FIGURE 32 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2022)
11.1.2 BAXTER INTERNATIONAL, INC.
TABLE 148 BAXTER INTERNATIONAL, INC.: COMPANY OVERVIEW
FIGURE 33 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)
11.1.3 BOSTON SCIENTIFIC CORPORATION
TABLE 149 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
11.1.4 BECTON, DICKINSON AND COMPANY
TABLE 150 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
11.1.5 B. BRAUN MELSUNGEN AG
TABLE 151 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
FIGURE 36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
11.1.6 CARDINAL HEALTH
TABLE 152 CARDINAL HEALTH: COMPANY OVERVIEW
FIGURE 37 CARDINAL HEALTH: COMPANY SNAPSHOT (2022)
11.1.7 OLYMPUS CORPORATION
TABLE 153 OLYMPUS CORPORATION: COMPANY OVERVIEW
FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
11.1.8 INTUITIVE SURGICAL
TABLE 154 INTUITIVE SURGICAL: COMPANY OVERVIEW
FIGURE 39 INTUITIVE SURGICAL: COMPANY SNAPSHOT (2022)
11.1.9 COLOPLAST A/S
TABLE 155 COLOPLAST A/S: COMPANY OVERVIEW
FIGURE 40 COLOPLAST A/S: COMPANY SNAPSHOT (2022)
11.1.10 STRYKER CORPORATION
TABLE 156 STRYKER CORPORATION: COMPANY OVERVIEW
FIGURE 41 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
11.1.11 TELEFLEX INCORPORATED
TABLE 157 TELEFLEX INCORPORATED: COMPANY OVERVIEW
FIGURE 42 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
11.1.12 CONVATEC GROUP PLC
TABLE 158 CONVATEC GROUP PLC: COMPANY OVERVIEW
FIGURE 43 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2022)
11.1.13 MEDTRONIC PLC
TABLE 159 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 44 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
11.2 OTHER PLAYERS
11.2.1 KARL STORZ
11.2.2 COOK MEDICAL
11.2.3 RICHARD WOLF GMBH
11.2.4 COMPACTCATH
11.2.5 DORNIER MEDTECH
11.2.6 NIKKISO CO., LTD.
11.2.7 DIALIFE SA
11.2.8 ERBE VISION
11.2.9 WELL LEAD MEDICAL CO., LTD.
11.2.10 ROCAMED
11.2.11 ENDOMED SYSTEMS GMBH
11.2.12 AMSINO INTERNATIONAL, INC.
11.2.13 MEDISPEC
11.2.14 MEDICAL TECHNOLOGIES OF GEORGIA
11.2.15 VIMEX SP. Z O. O.
11.2.16 BALTON SP. Z O.O.
11.2.17 HUNTER UROLOGY (PART OF OPTIMUM MEDICAL GROUP)
11.2.18 RIBBEL INTERNATIONAL LIMITED
*Details on Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
